Maoqiang Li

机构：Hangzhou First People's Hospital

发表论文 56 篇 · 总被引 901 次 · h-index 17

代表论文

• Targeting macrophagic PIM-1 alleviates osteoarthritis by inhibiting NLRP3 inflammasome activation via suppressing mitochondrial ROS/Cl− efflux signaling pathway (2023 · Journal of Translational Medicine · 被引 47)
• Extracellular vesicles from bone marrow mesenchymal stem cells alleviate osteoporosis in mice through USP7-mediated YAP1 protein stability and the Wnt/β-catenin pathway (2023 · Biochemical Pharmacology · 被引 44)
• Comparison of minimally invasive transforaminal lumbar interbody fusion and endoscopic lumbar interbody fusion for lumbar degenerative diseases: a retrospective observational study (2023 · Journal of Orthopaedic Surgery and Research · 被引 23)
• METTL14 upregulates TCF1 through m6A mRNA methylation to stimulate osteogenic activity in osteoporosis (2022 · Human Cell · 被引 21)
• Urolithin a attenuates rheumatoid arthritis by inhibiting inflammation and pyroptosis in fibroblasts via the AMPK/ NF-κB signaling pathway (2025 · International Immunopharmacology · 被引 16)
• Peptide 11R‑VIVIT promotes fracture healing in osteoporotic rats (2021 · International Journal of Molecular Medicine · 被引 8)